{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:35:54Z","timestamp":1775154954039,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sapharm.2024.08.091","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:47:46Z","timestamp":1724827666000},"page":"1102-1109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Development and validation of a predictive scoring model for risk stratification of tuberculosis treatment interruption"],"prefix":"10.1016","volume":"20","author":[{"given":"Ai Ling","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0592-0645","authenticated-orcid":false,"given":"Mohd","family":"Makmor-Bakry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida","family":"Islahudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuo Yew","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swee Kim","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew Teck","family":"Tie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.08.091_bib1","series-title":"Global Tuberculosis Report","year":"2022"},{"key":"10.1016\/j.sapharm.2024.08.091_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.943545","article-title":"Drug resistant tuberculosis: implications for transmission, diagnosis, and disease management","volume":"12","author":"Liebenberg","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.sapharm.2024.08.091_bib3","series-title":"WHO Consolidated Guidelines on Tuberculosis. Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment","year":"2022"},{"issue":"1","key":"10.1016\/j.sapharm.2024.08.091_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-010592","article-title":"Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis","volume":"8","author":"Oh","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.sapharm.2024.08.091_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210422","article-title":"Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis","volume":"14","author":"Zegeye","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2024.08.091_bib6","series-title":"Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care, 2017 Update","year":"2017"},{"key":"10.1016\/j.sapharm.2024.08.091_bib7","series-title":"Definitions and Reporting Framework for Tuberculosis \u2013 2013 Revision: Updated December 2014 and January 2020","year":"2013"},{"key":"10.1016\/j.sapharm.2024.08.091_bib8","unstructured":"Summary of Tuberculosis Data: Tuberculosis in Malaysia. World Health Organization; 2021. https:\/\/worldhealthorg.shinyapps.io\/TBrief\/. [Accessed 7 June 2023]."},{"issue":"4","key":"10.1016\/j.sapharm.2024.08.091_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231986","article-title":"Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: a registry-based cohort study","volume":"15","author":"Tok","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2024.08.091_bib10","doi-asserted-by":"crossref","first-page":"B","DOI":"10.2471\/BLT.07.043802","article-title":"Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment","volume":"86","author":"Awofeso","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.sapharm.2024.08.091_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41598-021-04742-2","article-title":"Risk factors for early TB treatment interruption among newly diagnosed patients in Malaysia","volume":"12","author":"Suliman","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.sapharm.2024.08.091_bib12","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s11606-021-06648-1","article-title":"An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks","volume":"36","author":"Peh","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.sapharm.2024.08.091_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw566","article-title":"Executive summary: official american thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sapharm.2024.08.091_bib14","series-title":"Toman's Tuberculosis Case Detection, Treatment, and Monitoring: Questions and Answers","author":"Frieden","year":"2004"},{"issue":"12","key":"10.1016\/j.sapharm.2024.08.091_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2024.08.091_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1755-8794-4-31","article-title":"Optimally splitting cases for training and testing high dimensional classifiers","volume":"4","author":"Dobbin","year":"2011","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.sapharm.2024.08.091_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.psych.58.110405.085530","article-title":"Missing data analysis: making it work in the real world","volume":"60","author":"Graham","year":"2009","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.sapharm.2024.08.091_bib18","volume":"2nd","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.sapharm.2024.08.091_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3762651","article-title":"Defining an optimal cut-point value in roc analysis: an alternative approach","author":"Unal","year":"2017","journal-title":"Comput Math Methods Med"},{"issue":"9","key":"10.1016\/j.sapharm.2024.08.091_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000146","article-title":"Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis","volume":"6","author":"Menzies","year":"2009","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.sapharm.2024.08.091_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijtb.2019.11.005","article-title":"Adverse drug reactions in tuberculosis and management","volume":"66","author":"Prasad","year":"2019","journal-title":"Indian J Tubercul"},{"issue":"5","key":"10.1016\/j.sapharm.2024.08.091_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21315\/mjms2018.25.5.10","article-title":"Evaluation of adverse reactions induced by anti-tuberculosis drugs in Hospital Pulau Pinang","volume":"25","author":"Fei","year":"2018","journal-title":"Malays J Med Sci"},{"key":"10.1016\/j.sapharm.2024.08.091_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2021.748310","article-title":"Adverse drug reactions related to treatment of drug-susceptible tuberculosis in Brazil: a prospective cohort study","volume":"2","author":"Sant\u00c1nna","year":"2022","journal-title":"Front Trop Dis"},{"issue":"6","key":"10.1016\/j.sapharm.2024.08.091_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","article-title":"Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis","volume":"77","author":"Pradipta","year":"2018","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.sapharm.2024.08.091_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5588\/ijtld.23.0078","article-title":"Clinical standards for the management of adverse effects during treatment for TB","volume":"27","author":"Singh","year":"2023","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.sapharm.2024.08.091_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/PPA.S60927","article-title":"The association of smoking with medical treatment adherence in the workforce of a large employer","volume":"8","author":"Sherman","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.sapharm.2024.08.091_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.625078","article-title":"Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients","volume":"12","author":"Bea","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.sapharm.2024.08.091_bib28","first-page":"1","article-title":"Determinants of default from pulmonary tuberculosis treatment in Kuwait","author":"Zhang","year":"2014","journal-title":"Sci World J"},{"issue":"4","key":"10.1016\/j.sapharm.2024.08.091_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jegh.2017.08.003","article-title":"Establishing a cohort in a developing country: experiences of the diabetes-tuberculosis treatment outcome cohort study","volume":"7","author":"Mukhtar","year":"2017","journal-title":"J Epidemiol Glob Health"},{"issue":"2","key":"10.1016\/j.sapharm.2024.08.091_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3346\/jkms.2016.31.2.254","article-title":"Predictors of default from treatment for tuberculosis: a single center case-control study in Korea","volume":"31","author":"Park","year":"2016","journal-title":"J Kor Med Sci"},{"issue":"7","key":"10.1016\/j.sapharm.2024.08.091_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.sapharm.2024.08.091_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12257","article-title":"Acquired immunodeficiencies and tuberculosis: focus on HIV\/AIDS and diabetes mellitus","volume":"264","author":"Ronacher","year":"2015","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.sapharm.2024.08.091_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0023-2016","article-title":"Diabetes and tuberculosis","volume":"4","author":"Restrepo","year":"2016","journal-title":"Microbiol Spectr"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124003450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124003450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T05:30:54Z","timestamp":1731994254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124003450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1551741124003450"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.08.091","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a predictive scoring model for risk stratification of tuberculosis treatment interruption","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.08.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}